Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003299
Filing Date
2025-03-19
Accepted
2025-03-19 16:07:18
Documents
119
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ipsc-20241231x10k.htm   iXBRL 10-K 2783562
2 EX-19.1 ipsc-20241231xex19d1.htm EX-19.1 50357
3 EX-21.1 ipsc-20241231xex21d1.htm EX-21.1 4585
4 EX-23.1 ipsc-20241231xex23d1.htm EX-23.1 7384
5 EX-31.1 ipsc-20241231xex31d1.htm EX-31.1 12678
6 EX-31.2 ipsc-20241231xex31d2.htm EX-31.2 12699
7 EX-32.1 ipsc-20241231xex32d1.htm EX-32.1 6889
8 EX-32.2 ipsc-20241231xex32d2.htm EX-32.2 6832
9 GRAPHIC ipsc-20241231x10k002.jpg GRAPHIC 68998
10 GRAPHIC ipsc-20241231x10k003.jpg GRAPHIC 78911
11 GRAPHIC ipsc-20241231x10k004.jpg GRAPHIC 81709
12 GRAPHIC ipsc-20241231x10k005.jpg GRAPHIC 54595
13 GRAPHIC ipsc-20241231x10k006.jpg GRAPHIC 184191
14 GRAPHIC ipsc-20241231x10k007.jpg GRAPHIC 86497
15 GRAPHIC ipsc-20241231x10k008.jpg GRAPHIC 78811
16 GRAPHIC ipsc-20241231x10k009.jpg GRAPHIC 125008
17 GRAPHIC ipsc-20241231x10k010.jpg GRAPHIC 25302
  Complete submission text file 0001558370-25-003299.txt   13874391

Data Files

Seq Description Document Type Size
18 EX-101.SCH ipsc-20241231.xsd EX-101.SCH 77307
19 EX-101.CAL ipsc-20241231_cal.xml EX-101.CAL 103471
20 EX-101.DEF ipsc-20241231_def.xml EX-101.DEF 278411
21 EX-101.LAB ipsc-20241231_lab.xml EX-101.LAB 702794
22 EX-101.PRE ipsc-20241231_pre.xml EX-101.PRE 534083
122 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20241231x10k_htm.xml XML 1992036
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40498 | Film No.: 25752736
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)